Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

A New Immune System Cell Discovered: The Phospholipid-Reactive T Cell

A New Immune System Cell Discovered: The Phospholipid-Reactive T Cell

One of the most important cells in our immune system is the T cells population. T cells help defend our bodies against pathogens and cancer formation. In recent years in particular, T cells have gained importance in cancer immunotherapy. In December 2018, a study in European Journal of Immunology reported that a new type of T cell that recognizes phospholipids in the cell membrane had been discovered. It is stated that this type of T cell could play an important role in autoimmune diseases and cancer.

The research was conducted at the UCLA Jonsson Cancer Center and the La Jolla Institute for Immunology in the United States.

As we know, cells are the basic building blocks of our bodies. Within cells, the most critical events occur at the cell membrane. Cell membranes consist of two types of lipid (fat) molecules: phospholipids and glycolipids. Inside the cell, these lipids are bound to the CD1d molecule. The CD1d molecule transports lipids to the cell surface.

In the research;

  • Phospholipids were discovered to activate a different type of T cell, which was named the phospholipid-reactive T cell . Glycolipids, meanwhile, activate iNKT (innate Natural Killer T-cells). These cells protect the body, particularly against cancer and autoimmune diseases. However, when iNKT cells become overactive, liver diseases such as hepatitis occur. The presence of phospholipids prevents excessive activation of these cells. For this reason, phospholipid-reactive cells are thought to maintain balance in the immune system.
  • It was also found that the number of phospholipid-reactive T cells in the body is quite small (%2 of all lymphocytes). So what does this study mean for us?
  • The newly discovered phospholipid-reactive T cells are thought to play a role in alcohol-related hepatitis, dyslipidemia, cancer and autoimmune disorders.
  • The importance of T cells in cancer is increasing every day. These developments shed light on the development of effective cancer immunotherapies. -

Below, you can see the graphical abstract of the article:

iNKT cell CD1d phospholipid-reactive T cell PLT

Explanation:

Glycerophospholipids (GPL) bind the lipid antigen-presenting CD1d molecule and activate phospholipid-reactive T cells (PLT). GPLs compete with glycerosphingolipids (GSL) from inside and outside the cell to bind CD1d, and this keeps iNKT cells inactive.

Sources

Ramesh Chandra Halder ve ark.
Self‐glycerophospholipids activate murine phospholipid‐reactive T cells and inhibit iNKT cell activation by competing with ligands for CD1d loading.
European Journal of Immunology, 03 December 2018.

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

A New Immune System Cell Discovered: The Phospholipid-Reactive T Cell

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy